• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝和胰腺脂肪变性与 COVID-19 肺炎总严重程度评分和预后的关系,重点是预后强度。

Relationship between hepatic and pancreatic steatosis and the COVID-19 pneumonia total severity score and prognosis with an emphasis on prognostic strength.

机构信息

Department of Radiology, Koç University Faculty of Medicine, İstanbul, Turkey.

Medical Student, Koç University Faculty of Medicine, İstanbul, Turkey.

出版信息

Diagn Interv Radiol. 2023 Jul 20;29(4):363-370. doi: 10.4274/dir.2022.221730. Epub 2022 Dec 21.

DOI:10.4274/dir.2022.221730
PMID:36960637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10679637/
Abstract

PURPOSE

To investigate the relationship between hepatic steatosis (HS), pancreatic steatosis (PS), and coexisting HS and PS and the Coronavirus disease-2019 (COVID-19) pneumonia total severity score (TSS) and prognosis, assessed through computed tomography (CT), and to evaluate the degree of effectiveness of the three steatosis conditions on TSS and prognosis.

METHODS

This retrospective study involved 461 patients (255 male and 206 female, median age of 53 years) with COVID-19 who underwent unenhanced chest CT. HS, PS, and coexisting HS and PS, assessed through CT, were compared with patient demographics, comorbidities, TSS, hospitalization and intubation requirements, and mortality rates. The parameters were compared using Mann-Whitney U and chi-square tests. The parameters of three groups of patients with only HS, only PS, and both HS and PS were compared using the Kruskal-Wallis test.

RESULTS

Results revealed that TSS ( < 0.001 for all) and hospitalization rates ( < 0.001 for all except for HS [ = 0.004]) were higher in patients with HS, PS, and both than in those without. Intubation ( = 0.003) and mortality rates ( = 0.018) were significantly higher solely in patients with PS. However, TSS, hospitalization, and diabetes mellitus were significantly higher than in age-standardized analyses for PS. In a comparison between only HS, only PS, and coexisting HS and PS in 210 patients, the highest TSS was in the coexistence group ( < 0.001).

CONCLUSION

The TSS and hospitalization rates correlate with HS, PS, and coexisting HS and PS, whereas intubation and mortality rates only correlate with PS. However, TSS correlates with coexisting HS and PS at the highest rate.

摘要

目的

通过计算机断层扫描(CT)评估肝脂肪变性(HS)、胰腺脂肪变性(PS)以及共存的 HS 和 PS 与 2019 年冠状病毒病(COVID-19)肺炎总严重程度评分(TSS)和预后的关系,并评估这三种脂肪变性情况对 TSS 和预后的有效性程度。

方法

本回顾性研究纳入了 461 名 COVID-19 患者(255 名男性,206 名女性,中位年龄 53 岁),均接受了未增强胸部 CT 检查。通过 CT 评估 HS、PS 以及共存的 HS 和 PS,并将其与患者的人口统计学特征、合并症、TSS、住院和插管需求以及死亡率进行比较。采用 Mann-Whitney U 和卡方检验对参数进行比较。采用 Kruskal-Wallis 检验比较仅存在 HS、仅存在 PS 以及同时存在 HS 和 PS 的三组患者的参数。

结果

结果显示,在存在 HS、PS 以及共存的 HS 和 PS 的患者中,TSS(均<0.001)和住院率(均<0.001,除了 HS[=0.004])均高于无 HS、PS 以及共存的 HS 和 PS 的患者。仅 PS 患者的插管率(=0.003)和死亡率(=0.018)显著更高。然而,在 PS 的年龄标准化分析中,TSS、住院和糖尿病的发生率显著更高。在 210 例仅存在 HS、仅存在 PS 和共存的 HS 和 PS 的患者之间进行比较时,共存组的 TSS 最高(<0.001)。

结论

TSS 和住院率与 HS、PS 以及共存的 HS 和 PS 相关,而插管率和死亡率仅与 PS 相关。然而,TSS 与共存的 HS 和 PS 的相关性最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/c7ba68cb4be6/DIR-29-563-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/6e252a1f9125/DIR-29-563-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/5a80e9757685/DIR-29-563-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/aec7054d1c95/DIR-29-563-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/c7ba68cb4be6/DIR-29-563-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/6e252a1f9125/DIR-29-563-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/5a80e9757685/DIR-29-563-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/aec7054d1c95/DIR-29-563-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5a/10679637/c7ba68cb4be6/DIR-29-563-g4.jpg

相似文献

1
Relationship between hepatic and pancreatic steatosis and the COVID-19 pneumonia total severity score and prognosis with an emphasis on prognostic strength.肝和胰腺脂肪变性与 COVID-19 肺炎总严重程度评分和预后的关系,重点是预后强度。
Diagn Interv Radiol. 2023 Jul 20;29(4):363-370. doi: 10.4274/dir.2022.221730. Epub 2022 Dec 21.
2
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis.胰腺脂肪变性的计算机断层扫描评估:与COVID-19预后的相关性
Future Virol. 2022 Jan. doi: 10.2217/fvl-2021-0257. Epub 2021 Feb 10.
3
Can Opportunistic Use of Computed Tomography Help Reveal the Association Between Hepatic Steatosis and Disease Severity in Hospitalized COVID-19 Patients?对住院的COVID-19患者进行计算机断层扫描的机会性使用能否有助于揭示肝脂肪变性与疾病严重程度之间的关联?
Rofo. 2025 Jun;197(6):648-656. doi: 10.1055/a-2369-8377. Epub 2024 Aug 21.
4
Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.无症状合并肝脂肪变成人的冠状动脉 CT 血管造影
Radiology. 2021 Dec;301(3):593-601. doi: 10.1148/radiol.2021210355. Epub 2021 Sep 21.
5
Role of hepatosteatosis in the prognosis of COVID 19 disease.肝脂肪变性在 COVID-19 疾病预后中的作用。
Clin Imaging. 2021 Dec;80:1-5. doi: 10.1016/j.clinimag.2021.06.034. Epub 2021 Jun 26.
6
Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.肝脂肪变性的量化:活体肝移植供体候选人中计算机断层扫描和磁共振指数的比较
Acad Radiol. 2014 Apr;21(4):507-13. doi: 10.1016/j.acra.2014.01.007.
7
Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.肝脂肪变性与 2019 冠状病毒病严重程度增加和肝损伤有关。
Dig Dis Sci. 2021 Sep;66(9):3192-3198. doi: 10.1007/s10620-020-06618-3. Epub 2020 Sep 27.
8
Comparison of chest CT severity scoring systems for COVID-19.COVID-19 患者胸部 CT 严重程度评分系统比较。
Eur Radiol. 2022 May;32(5):3501-3512. doi: 10.1007/s00330-021-08432-5. Epub 2022 Jan 15.
9
Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia.比较半定量胸部 CT 评分系统以评估 2019 冠状病毒病(COVID-19)肺炎的严重程度。
Eur Radiol. 2022 May;32(5):3513-3524. doi: 10.1007/s00330-021-08435-2. Epub 2022 Jan 12.
10
Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients.成年新冠病毒肺炎患者肝脏脂肪变性的发生率及其与胸部计算机断层扫描肺炎严重程度评分的相关性
World J Crit Care Med. 2021 May 9;10(3):47-57. doi: 10.5492/wjccm.v10.i3.47.

引用本文的文献

1
Role of CT-based body composition parameters in the course of COVID-19.CT 体成分参数在 COVID-19 病程中的作用。
Turk J Med Sci. 2024 Apr 24;54(5):1071-1081. doi: 10.55730/1300-0144.5886. eCollection 2024.

本文引用的文献

1
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis.胰腺脂肪变性的计算机断层扫描评估:与COVID-19预后的相关性
Future Virol. 2022 Jan. doi: 10.2217/fvl-2021-0257. Epub 2021 Feb 10.
2
Gastrointestinal Disease and COVID-19: A Review of Current Evidence.胃肠道疾病与 COVID-19:现有证据综述。
Dig Dis. 2022;40(4):506-514. doi: 10.1159/000519412. Epub 2021 Sep 10.
3
Role of hepatosteatosis in the prognosis of COVID 19 disease.肝脂肪变性在 COVID-19 疾病预后中的作用。
Clin Imaging. 2021 Dec;80:1-5. doi: 10.1016/j.clinimag.2021.06.034. Epub 2021 Jun 26.
4
Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19.胸部CT严重程度评分:一种评估重症COVID-19的影像学工具。
Radiol Cardiothorac Imaging. 2020 Mar 30;2(2):e200047. doi: 10.1148/ryct.2020200047. eCollection 2020 Apr.
5
The effect of hepatic steatosis on COVID-19 severity: Chest computed tomography findings.肝脂肪变性对 COVID-19 严重程度的影响:胸部 CT 表现。
Saudi J Gastroenterol. 2021 Mar-Apr;27(2):105-110. doi: 10.4103/sjg.sjg_540_20.
6
Liver injury in the era of COVID-19.COVID-19 时代的肝损伤。
World J Gastroenterol. 2021 Feb 7;27(5):377-390. doi: 10.3748/wjg.v27.i5.377.
7
Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients.计算机断层扫描胰腺脂肪变性是预测性诊断胰腺癌的早期影像学特征:超重患者的初步研究。
Pancreatology. 2021 Mar;21(2):428-433. doi: 10.1016/j.pan.2021.01.003. Epub 2021 Jan 16.
8
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.住院患者病死率与 COVID-19 住院的非酒精性脂肪性肝病患者的炎症反应相关。
PLoS One. 2020 Oct 8;15(10):e0240400. doi: 10.1371/journal.pone.0240400. eCollection 2020.
9
Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.肝脂肪变性与 2019 冠状病毒病严重程度增加和肝损伤有关。
Dig Dis Sci. 2021 Sep;66(9):3192-3198. doi: 10.1007/s10620-020-06618-3. Epub 2020 Sep 27.
10
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study.非酒精性脂肪性肝病与 COVID-19 严重程度相关,与代谢综合征无关:一项回顾性病例对照研究。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(12):1578-1581. doi: 10.1097/MEG.0000000000001902.